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The present volume maintains the high
standards set by its predecessors. Dr Muggia
has joined the editorial team to provide
additional expertise in the field of oncology,
and to broaden the appeal of the series,
though the spectrum oftopics included is still
likely to be of interest predominantly to the
clinical haematologist rather than the on-
cologist. Amongst chapters which should
interest the latter, however, are those by
Dr Fialkow on the clonal and stem-cell origins
of blood-cell neoplasms, Drs Marks and
McCaffrey on terminal transferase and Drs
Cohen and Cathcart on amyloidosis. The
chapter on the molecular genetics of thalas-
saemia by Drs Orkin and Nathan, and that
on theeffect ofheparin on complement activa-
tion, by Drs Logue and Kelton, will be of
special interest to the haematologist. Drs
Schiffer and Aisner's essay on a rational
approach togranulocyte transfusions istimely
and thoughtful. All these subjects and several
others are discussed by experts in, for the
most part, a commendably lucid style.
Together with the 1977 and 1978 Year
Books, the editors have succeeded in covering
manyofthe "growingpoints" inhaematology,
and the reader who has digested all these
will indeed be well informed, though, to be
sure, at no inconsiderable cost to his pocket!
The editors conclude their preface to the
latest volume wistfully, by pointing out that
some ingenuity is needed to find topics not
already covered in this and comparable series.
Sofartheyhaveachievedtheiraimadmirably.
C. G. GEARY
The Anticancer Drugs. W. B. PRATT &
R. W. RUDDON (1979). Oxford University
Press. 323 pp. £8-50.
This book is a comprehensive account of
currently used cytotoxic agents for cancer
therapy. In general, the text is well pre-
sented and produced in a very readable for-
mat. The initial problem of cancer and the
reasons for drug response are discussed in
some detail, and there follows a description
of individual cytotoxic drugs. Each chapter
is followed by an adequate list of references
for the reader wishing to study a particular
drug in more detail.
I think it would be unlikely to appeal to
current workers in cancer therapy, as it does
not contain sufficient detail. However, its
form is attractive enough to appeal to workers
in other disciplines, and short enough to be
read even by medical students. In support of
this is the attractive price of £8-50 which,
considering the cost of medical texts, is a
considerable achievement for the publishers.
P. WILKINSON